<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page2_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page2_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title> </title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>jennifer</o:LastAuthor>
  <o:Revision>12</o:Revision>
  <o:TotalTime>101</o:TotalTime>
  <o:Created>2006-10-03T13:31:00Z</o:Created>
  <o:LastSaved>2006-10-12T13:17:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>592</o:Words>
  <o:Characters>3379</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>28</o:Lines>
  <o:Paragraphs>6</o:Paragraphs>
  <o:CharactersWithSpaces>4149</o:CharactersWithSpaces>
  <o:Version>9.6926</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>75</w:Zoom>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1 -369098753 63 0 4129023 0;}
@font-face
	{font-family:"\@Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1 -369098753 63 0 4129023 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-fareast-font-family:"Arial Unicode MS";
	mso-font-kerning:16.0pt;}
h2
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:14.0pt;
	font-family:Arial;
	mso-fareast-font-family:"Arial Unicode MS";
	font-style:italic;}
h3
	{mso-style-next:Normal;
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:12.0pt;
	font-family:"Times New Roman";
	color:navy;
	font-weight:normal;
	font-style:italic;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1029"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal><a href="http://www.ebi.ac.uk/interpro/"
title="To the InterPro database"><span style='text-decoration:none;text-underline:
none'><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
 o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
 stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:139.5pt;
 height:45pt'>
 <v:imagedata src="./Page2_files/image001.png" o:title="InterPro"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=186 height=60
src="./Page2_files/image002.jpg" v:shapes="_x0000_i1025"><![endif]></span></a></p>

<h1 align=center style='text-align:center'><span style='font-size:28.0pt;
mso-bidi-font-size:16.0pt;color:navy'>Cytochrome&nbsp;P450<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='font-size:14.0pt;mso-bidi-font-size:16.0pt;color:navy'>A Wealth
of Enzymes<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>In
mammals, CYP enzymes can oxidise a variety of different substrates, including
steroids, fatty acids and xenobiotics.<span style="mso-spacerun: yes"> 
</span>Of the thousands of CYP proteins identified, 58 have been found in
humans alone.<span style="mso-spacerun: yes">  </span>Individual CYP proteins
follow the nomenclature: CYP, followed by a number (family), then a letter
(subfamily), and another number (protein); e.g. CYP3A4 is the fourth protein in
family 3, subfamily A.<span style="mso-spacerun: yes">  </span>The different
CYP enzymes have different substrate specificities, and are often restricted to
specific cell types as well.<span style="mso-spacerun: yes">  </span>For
example, CYP2J2 is involved in arachidonic acid metabolism and is primarily
expressed in the heart, while CYP2D6 is involved in the degradation of
xenobiotics such as codeine, and is primarily expressed in the liver.</p>

<p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h3>Alternative splicing </h3>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>Alternative
splicing has been found to occur with many CYP proteins, which further
increases their genetic diversity and may be involved in the regulation of
transcription of certain CYP proteins.<span style="mso-spacerun: yes"> 
</span>Some of these splice-variants are tissue-specific.<span
style="mso-spacerun: yes">  </span>In addition to alternative splicing,
tissue-specific gene promoters allow greater versatility in the regulation of
CYP proteins within specific tissues.</p>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h3>Fusion Enzymes </h3>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>Some
CYP proteins have been found to exist as fused domains with one or more of
their redox partners, which can have the evolutionary advantage of increasing
catalytic efficiency.<span style="mso-spacerun: yes">  </span>Fusion proteins
have been found in both prokaryotic and eukaryotic systems, with a wide variety
of cytochrome P450/redox partner fusions.<span style="mso-spacerun: yes"> 
</span>For example, in <i>B. megaterium</i>, soluble cytochrome P450 is
covalently linked to a reductase enzyme to produce a highly efficient system
for the oxygenation of fatty acids.<span style="mso-spacerun: yes">  </span>In
another bacterial system, CYP has been found attached as an N-terminal domain
to a phthalate dioxygenase reductase module, which allows the reductase to
facilitate the breakdown and metabolism of aromatic phthalate.<span
style="mso-spacerun: yes">  </span></p>

<p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h3 style='text-align:justify'>Polymorphic variations </h3>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>People
can carry different alleles of CYP genes, these alleles having a slight
variation in their genetic sequence due to nucleotide changes, or
polymorphisms.<span style="mso-spacerun: yes">  </span>These polymorphic
variations can result in individual and population differences in the tolerance
to toxins and drugs.<span style="mso-spacerun: yes">  </span>Because CYP
proteins are specific in terms of which drugs they clear and which they
activate, polymorphic variations in different CYP genes can have different
effects.<span style="mso-spacerun: yes">  </span>Furthermore, whether the gene
is rendered more active or less active can have opposing effects.</p>

<p class=MsoNormal style='text-align:justify;text-indent:36.0pt'>For example,
CYP2D6 is expressed at high levels in many people from Saudi Arabia and
Ethiopia.<span style="mso-spacerun: yes">  </span>CYP2D6 can degrade and clear
several drugs, including anti-depressants and neuroleptics, making them
ineffective if the level of CYP2D6 is too high.<span style="mso-spacerun:
yes">  </span>In addition, CYP2D6 can turn other drugs into active metabolites,
such as converting codeine into the more potent morphine, which can reach dangerous
levels in people with elevated CYP2D6 levels.<span style="mso-spacerun: yes"> 
</span>By contrast, people deficient in CYP2D6 will have the reverse effects, namely
a predisposition to drug toxicity when taking anti-depressants and neuroleptics
(which are not broken down efficiently if CYP2D6 is absent), while finding
codeine ineffective.</p>

<p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2 align=center style='text-align:center'><span style='font-size:16.0pt;
mso-bidi-font-size:14.0pt;font-style:normal'>Next:<span style="mso-spacerun:
yes">  </span><a href="Page3.htm" title="Page 3">Cytochrome P450 and the Drug
Response</a><o:p></o:p></span></h2>

<h2 align=center style='text-align:center'><span style='font-size:16.0pt;
mso-bidi-font-size:14.0pt;font-style:normal'>Previous:<span
style="mso-spacerun: yes">  </span><a href="Page1.htm" title="Page 1">Cytochrome
P450, Detox Proteins</a></span></h2>

</div>

</body>

</html>
